中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
CHINESE JOURNAL OF MINIMALLY INVASIVE SURGERY
2014年
7期
597-599,602
,共4页
刘永珠%胡庆兰%陈日利%朱伟艳%吴海燕%彭奕琼
劉永珠%鬍慶蘭%陳日利%硃偉豔%吳海燕%彭奕瓊
류영주%호경란%진일리%주위염%오해연%팽혁경
早期卵巢癌%腹腔镜手术%开腹手术
早期卵巢癌%腹腔鏡手術%開腹手術
조기란소암%복강경수술%개복수술
Early-stage ovarian cancer%Laparoscopic surgery%Open surgery
目的:比较腹腔镜和开腹手术治疗早期卵巢癌的疗效。方法回顾性分析2009年1月~2013年12月我院手术治疗的早期卵巢癌48例,其中腹腔镜手术25例(腹腔镜组),开腹手术23例(开腹组),比较2组手术时间、术中出血量、术后住院时间、肛门排气时间、术后并发症及切口感染率等。结果腹腔镜组术中出血量(150.2±50.8)ml,明显少于开腹组(235.6±49.3)ml(t=-5.901,P=0.000);腹腔镜组术后肛门排气时间(36.2±13.5)h,明显早于开腹组(48.3±13.9)h (t=-3.058,P=0.004);腹腔镜组术后发热6例,显著少于开腹组12例(χ2=4.057,P=0.044);腹腔镜组术后切口感染2例,与开腹组6例无统计学差异(χ2=1.670,P=0.196);腹腔镜组住院时间(15.2±5.2) d,明显短于开腹组(23.3±4.2) d (t=5.904,P=0.000)。2组手术时间分别为(241.4±45.3)、(248.5±58.3)min,无统计学差异(t=-0.473,P=0.638);2组切除淋巴结分别(21.3±2.9)、(20.5±3.0)枚,无统计学差异(t=0.939,P=0.353)。45例(开腹组2例失访,腹腔镜组1例失访)随访1~52个月,平均21.5月。开腹组2例分别术后10、12个月复发,腹腔镜组1例术后10个月复发,其余无瘤生存。结论腹腔镜手术治疗早期卵巢癌近期疗效好,安全可行,可作为早期卵巢癌手术治疗的新选择。
目的:比較腹腔鏡和開腹手術治療早期卵巢癌的療效。方法迴顧性分析2009年1月~2013年12月我院手術治療的早期卵巢癌48例,其中腹腔鏡手術25例(腹腔鏡組),開腹手術23例(開腹組),比較2組手術時間、術中齣血量、術後住院時間、肛門排氣時間、術後併髮癥及切口感染率等。結果腹腔鏡組術中齣血量(150.2±50.8)ml,明顯少于開腹組(235.6±49.3)ml(t=-5.901,P=0.000);腹腔鏡組術後肛門排氣時間(36.2±13.5)h,明顯早于開腹組(48.3±13.9)h (t=-3.058,P=0.004);腹腔鏡組術後髮熱6例,顯著少于開腹組12例(χ2=4.057,P=0.044);腹腔鏡組術後切口感染2例,與開腹組6例無統計學差異(χ2=1.670,P=0.196);腹腔鏡組住院時間(15.2±5.2) d,明顯短于開腹組(23.3±4.2) d (t=5.904,P=0.000)。2組手術時間分彆為(241.4±45.3)、(248.5±58.3)min,無統計學差異(t=-0.473,P=0.638);2組切除淋巴結分彆(21.3±2.9)、(20.5±3.0)枚,無統計學差異(t=0.939,P=0.353)。45例(開腹組2例失訪,腹腔鏡組1例失訪)隨訪1~52箇月,平均21.5月。開腹組2例分彆術後10、12箇月複髮,腹腔鏡組1例術後10箇月複髮,其餘無瘤生存。結論腹腔鏡手術治療早期卵巢癌近期療效好,安全可行,可作為早期卵巢癌手術治療的新選擇。
목적:비교복강경화개복수술치료조기란소암적료효。방법회고성분석2009년1월~2013년12월아원수술치료적조기란소암48례,기중복강경수술25례(복강경조),개복수술23례(개복조),비교2조수술시간、술중출혈량、술후주원시간、항문배기시간、술후병발증급절구감염솔등。결과복강경조술중출혈량(150.2±50.8)ml,명현소우개복조(235.6±49.3)ml(t=-5.901,P=0.000);복강경조술후항문배기시간(36.2±13.5)h,명현조우개복조(48.3±13.9)h (t=-3.058,P=0.004);복강경조술후발열6례,현저소우개복조12례(χ2=4.057,P=0.044);복강경조술후절구감염2례,여개복조6례무통계학차이(χ2=1.670,P=0.196);복강경조주원시간(15.2±5.2) d,명현단우개복조(23.3±4.2) d (t=5.904,P=0.000)。2조수술시간분별위(241.4±45.3)、(248.5±58.3)min,무통계학차이(t=-0.473,P=0.638);2조절제림파결분별(21.3±2.9)、(20.5±3.0)매,무통계학차이(t=0.939,P=0.353)。45례(개복조2례실방,복강경조1례실방)수방1~52개월,평균21.5월。개복조2례분별술후10、12개월복발,복강경조1례술후10개월복발,기여무류생존。결론복강경수술치료조기란소암근기료효호,안전가행,가작위조기란소암수술치료적신선택。
Objective To compare the efficacy of laparoscopic and open surgery for early-stag ovarian cancer ( EOC ) . Methods Outcomes of 48 patients with EOC who underwent either laparoscopic surgery ( laparoscopic surgery group , n=25) or open surery (open surgery group, n=23) from January 2009 to December 2013 were retrospectively analyzed.The intraoperative parameters and postoperative complications were compared between the two groups . Results The laparoscopic surgery group had significantly less intraoperative blood loss [(150.2 ±50.8) ml vs.(235.6 ±49.3) ml, t =-5.901, P =0.000], shorter recovery time of gastrointestinal function [(36.2 ±13.5) h vs.(48.3 ±13.9) h,t=-3.058, P=0.004], fewer postoperative fever (6 cases vs.12 cases,χ2 =4.057, P=0.044), fewer postoperative incision infections (2 cases vs.6 cases, χ2 =1.670, P=0.196), and shorter postoperative hospital stay [(15.2 ±5.2)d vs.(23.3 ±4.2) d,t=5.904, P=0.000] than those in the open surgery group, respectively.No significant difference was detected in the operation time [(241.4 ±45.3) min vs.(248.5 ±58.3) min, t =-0.473, P=0.638] and the number of lymph node removed [(21.3 ±2.9) vs.(20.5 ±3.0),t=0.939, P=0.353] between the two groups.A total of 45 patients were followed up for 1-52 months, with an average of 21.5 months.Recurrence was recorded in 2 cases in the laparoscopic surgery group (10 months and 12 months after operation) and in 1 case (10 months after operation) in the open surgery group .The remaining cases obtaied disease-free survival . Conclusion Laparoscopic surgery in the treatment of EOC has a good short-term efficacy,and can be used as a new choice for the operative treatment of EOC .